Disha Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 04-07-2024
- Paid Up Capital ₹ 0.33 M
as on 04-07-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -43.28%
(FY 2021)
- Profit -422.80%
(FY 2021)
- Ebitda -266.61%
(FY 2021)
- Net Worth -3.34%
(FY 2021)
- Total Assets 141.32%
(FY 2021)
About Disha Life Sciences
The Corporate was formerly known as Asclep Lifesciences Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.33 M, as per Ministry of Corporate Affairs (MCA) records.
Damendra Rana, Ashish Vaishnav, and Neha Vaishnav serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC053910
- Company No.
053910
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Disha Life Sciences Private Limited offer?
Disha Life Sciences Private Limited offers a wide range of products and services, including Graduation & High Education Programs, Medical Educational Service, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Disha Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Damendra Rana  | Director | 16-May-2008 | Current |
| Ashish Vaishnav | Additional Director | 29-Jul-2008 | Current |
| Neha Vaishnav | Director | 01-Apr-2013 | Current |
Financial Performance and Corporate Structure Insights of Disha Life Sciences.
Disha Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 43.28% decrease. The company also saw a substantial fall in profitability, with a 422.8% decrease in profit. The company's net worth dipped by a decrease of 3.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Disha Life Sciences?
In 2021, Disha Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Disha Life Sciences?
Unlock and access historical data on people associated with Disha Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Disha Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Disha Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
